Literature DB >> 6124875

Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.

A Pfeiffer, A Herz.   

Abstract

The presence of different types of opiate binding sites was investigated with the use of a computerized, weighted, nonlinear least-squares regression program. The experimental data were obtained from four groups. Each of three labeled opiate ligands was displaced using each of the same unlabeled ligands. The resulting nine different ligand combinations of each group were evaluated by use of a curve-fitting program. The four groups consisted of the kappa ligand ethylketocyclazocine, the sigma ligand SKF 10047, and the oripavine derivatives etorphine and diprenorphine, each in conjunction with the delta opiate receptor ligand (D-Ala2,D-Leu5)-enkephalin and the mu opiate receptor ligand dihydromorphine. The binding model which best fitted each of the four groups suggested the existence of three different binding sites in the rat brain homogenate. Two of these sites conform to the previously described mu and delta sites. A third site (R3) displayed high affinity for ethylketocyclazocine, SKF 10047, etorphine, and diprenorphine but very low affinity for dihydromorphine and [D-Ala2,D-Leu5]enkephalin. Naloxone, cyclazocine, and dynorphin-(1--13) had high affinity for R3. Behavioral data support the interpretation that the R3 site may represent a kappa site at which SKF 10047 acts antagonistically.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124875

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Detailed analysis of heterogeneity of [3H]naloxone binding sites in rat brain synaptosomes.

Authors:  M Szücs; A Borsodi; A Bogdány; J Gaál; J Batke; G Tóth
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

2.  Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects.

Authors:  R R Goodman; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  Comparison of the filtration and centrifugation methods for assaying [3H](D-ala2, D-leu5)enkephalin binding to mouse brain membranes.

Authors:  R W Barrett; J L Vaught
Journal:  Neurochem Res       Date:  1983-12       Impact factor: 3.996

4.  Selective opioid agonist and antagonist competition for [3H]-naloxone binding in amphibian spinal cord.

Authors:  L C Newman; D R Wallace; C W Stevens
Journal:  Brain Res       Date:  2000-11-24       Impact factor: 3.252

Review 5.  Sleep therapeutics and neuropsychiatric illness.

Authors:  Andrew D Krystal
Journal:  Neuropsychopharmacology       Date:  2019-08-03       Impact factor: 7.853

Review 6.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

7.  Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors.

Authors:  T Meo; C Gramsch; R Inan; V Höllt; E Weber; A Herz; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.

Authors:  H H Suh; L F Tseng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

9.  Radioreceptor assay of narcotic analgesics in serum.

Authors:  J Grevel; J Thomas; M L Richards; W Sadée
Journal:  Pharm Res       Date:  1984-09       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.